The Latest Cardiac and Vascular News
DiA’s cardiac ultrasound AI will be implemented into Healthcare Technology Company’s CPACS workflow automating echo labs readflow and improving insights for imaging specialists BEER SHEVA, Israel, March 15, 2022 /PRNewswire/ — DiA Imaging Analysis Ltd, a leading global provider of AI-powered ultrasound analysis software, announced today a multi-year agreement with Change Healthcare, a global […]
ATLANTA, March 14, 2022 /PRNewswire/ — Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today published its inaugural Corporate Responsibility Report detailing the company’s Environmental, Social, and Governance (ESG) initiatives. Artivion’s 2022 Corporate Responsibility Report details several of the company’s ESG efforts, including: Environmental initiatives to drive sustainability and limit […]
PHILADELPHIA, March 15, 2022 /PRNewswire/ — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing best-in-class, novel therapy for the treatment of hypertension, today announced the appointment of Adam Levy as the company’s new Chief Financial Officer (CFO) and Chief Business Officer (CBO). “We are pleased to announce Adam’s appointment and welcome […]
SANTA CLARA, Calif., March 14, 2022 /PRNewswire/ — Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that its board of directors has authorized a $20.0 million stock repurchase program. Semler Scientific may purchase shares on a discretionary basis from time […]
NovaGuide, the only autonomous transcranial Doppler ultrasound, is approved for use in Canada LOS ANGELES, Calif., March 15, 2022 (GLOBE NEWSWIRE) — NovaSignal Corp., a medical technology and data company specializing in the assessment and management of brain health, today announced that its NovaGuide™ Intelligent Ultrasound has been granted a Medical Device Licence […]
Topline data from Phase 2b ASPEN-COVID-19 clinical trial evaluating rNAPc2 as a potential treatment for COVID-19 anticipated in the last week of March 2022 WESTMINSTER, Colo., March 14, 2022 (GLOBE NEWSWIRE) — ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular […]
On track for top-line data in April 2022 WARRINGTON, Pa., March 15, 2022 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime […]
The REVERSE-HF study will evaluate ultrafiltration therapy for heart failure patients suffering from fluid overload MINNEAPOLIS, March 15, 2022 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE) today announced it has received independent Institutional Review Board (IRB) approval for the trial protocol of the company’s REVERSE-HF (Ultrafiltration Versus IV Diuretics in Worsening Heart Failure) clinical study […]
The Company celebrated its recognition for three Synapse solutions at KLAS Research’s 2022 Best In KLAS® Show Lexington, Mass., March 15, 2022 (GLOBE NEWSWIRE) — March 15, 2022 – Booth 3947 – FUJIFILM Healthcare Americas Corporation, a leading provider of enterprise imaging and informatics solutions, is showcasing its award-winning Synapse Enterprise Imaging portfolio […]
PARIS–(BUSINESS WIRE)–LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of chronic limb-threatening ischemia (CLTI), a severe form of peripheral artery disease (PAD), announced today that it has completed patient enrollment in the PROMISE II pivotal trial of the LimFlow System. The LimFlow System is designed […]
